GTBP

Q: What is the price of GT Biopharma (GTBP) today?

The price of GT Biopharma (GTBP) today is $ 0.45, with return of -80.87% compared to the last year. The price of GT Biopharma (GTBP) started the year trading around $ 0.79 and today it is at $ 0.45. Follow the real-time price chart, the historical price of GT Biopharma (GTBP) and international markets.

Q: When does GT Biopharma (GTBP) pay dividends?

GT Biopharma (GTBP) did not distribute dividends in the last year.

Q: Is GT Biopharma (GTBP) worth it?

Currently, GT Biopharma (GTBP) is priced at $ 0.45, with a P/E of -1.06%, representing a deviation of -786% from its historical average P/E. In the last year, the stock showed a variation of -80.87 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -80.87%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy GT Biopharma (GTBP) stock?

Investing in stocks of GT Biopharma (GTBP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of GT Biopharma (GTBP) yield today?

The yield of GT Biopharma (GTBP) was -4.36% in the last month, -80.87% in the last year and -99.84% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of GT Biopharma (GTBP) today, the total investment would be $ 44.95, based on the current price of $ 0.45.If past performance were to repeat, the return on your investment would be:In 1 year: $ 8.60In 5 years: $ 0.07In 10 years: $ 0.09It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GT Biopharma Inc.

Price

$ 0.45

return (12m)

-80.87%

p/e

-1.06

p/bv

2.02

DIVIDEND YIELD

0.00%

GTBP price

GTBP

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment GTBP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.36%

3 months

-44.99%

1 year

-80.87%

2 years

-89.70%

5 years

-99.84%

10 years

-99.81%

Fundamentals GTBP

review the fundamentals of GT Biopharma shares

P/E

-1.06

Sector: -5.82 Industry: -5.82

P/S (PSR)

Sector: -4.74 Industry: -4.74

P/BV

2.02

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-136.00%

Sector: -72.38% Industry: -72.38%

ROE

-190.50%

Sector: -84.15% Industry: -84.15%

ROIC

-9,116.09%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

0.00%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

0.00%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

0.00%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

-0.41

Sector: -5.52 Industry: -5.52

EV/EBIT

-0.41

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

1.44

Sector: 1.13 Industry: 1.13

BVPS

0.22

Sector: 1.63 Industry: 1.63

EPS

-0.42

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.71

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.29

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-28.25%

Sector: - Industry: -

Fundamentals GTBP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GTBP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT GT Biopharma

GT Biopharma Inc.

Average Investor10 user rating

4.0 (0 people)

United States

53 years

Founded: 1973

Time since IPO - - year

3

Employees

The Company GT Biopharma Inc. (United States), is listed on Nasdaq with a market value of $ 11.69 Millions, having an equity of $ 5.79 Millions.

With a total of 3 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -11.03 Millions.

As for its main indicators, the Company has a P/E ratio of -1.06, a P/BV ratio of 2.02 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker GTBP.

Market cap

$ 11.69 Millions

Net worth

$ 5.79 Millions

US$ 5,790,000.00

Assets

$ 8.11 Millions

US$ 8,110,000.00

Total Shares Outstanding

26.00 Millions

26,000,000

Average Daily Trading Volume

$ 980.05 Thousand

US$ 980,046.00

Sector

Health Care

Industry

Biotechnology

GTBP

GTBP revenue and profits

Financial Results GTBP

DRAG THE FRAME TO SEE MORE DATA

GTBP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of GT Biopharma (GTBP) today?

The price of GT Biopharma (GTBP) today is $ 0.45, with return of -80.87% compared to the last year. The price of GT Biopharma (GTBP) started the year trading around $ 0.79 and today it is at $ 0.45. Follow the real-time price chart, the historical price of GT Biopharma (GTBP) and international markets.

When does GT Biopharma (GTBP) pay dividends?

GT Biopharma (GTBP) did not distribute dividends in the last year.

Is GT Biopharma (GTBP) worth it?

Currently, GT Biopharma (GTBP) is priced at $ 0.45, with a P/E of -1.06%, representing a deviation of -786% from its historical average P/E. In the last year, the stock showed a variation of -80.87 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -80.87%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy GT Biopharma (GTBP) stock?

Investing in stocks of GT Biopharma (GTBP) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of GT Biopharma (GTBP) yield today?

The yield of GT Biopharma (GTBP) was -4.36% in the last month, -80.87% in the last year and -99.84% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of GT Biopharma (GTBP) today, the total investment would be $ 44.95, based on the current price of $ 0.45.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 8.60
In 5 years: $ 0.07
In 10 years: $ 0.09

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GTBP

GT Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GTBP

review the fundamentals of GT Biopharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT GT Biopharma

GT Biopharma Inc.

United States

53 years

3

PROFIT X PRICE GTBP

Financial Results GTBP

GTBP cash flow

Asset, Revenue and Profit Growth - GTBP

GTBP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions